Ph.D in Neuropsychopharmacololgy, Faculté des Sciences Pharmaceutiques et Biologique University René Descartes, Paris V
Assistant professor in Pharmacology/Neurosciences, Inserm 1107 NeuroDol, University d’Auvergne, France
-
Ferrier, J., Bayet-Robert, M., Dalmann, R., El Guerrab, A., Aissouni, Y., Graveron-Demilly, D., Chalus, M., Pinguet, J., Eschalier, A., Richard, D., Daulhac, L., Marchand, F. and Balayssac, D. (2015). Cholinergic Neurotransmission in the Posterior Insular Cortex Is Altered in Preclinical Models of Neuropathic Pain: Key Role of Muscarinic M2 Receptors in Donepezil-Induced Antinociception. J Neurosci 35(50): 16418-16430.
-
Khairnar, A., Marchand, F., Vidal, A., Etienne, M., Miladi, I., Auzeloux, P., Cachin, F., Eschalier, A., Chezal, J. M., Ardid, D. and Miot-Noirault, E. (2015). 99mTc-NTP 15-5 Imaging for Cartilage Involvement in Experimental Rheumatoid Arthritis: Comparison with Routinely Used Molecular Imaging Methods and Sensitivity to Chronic Nonsteroidal Antiinflammatory Drug Treatment. J Nucl Med 56(5): 798-804.
-
Gregoire, S., Wattiez, A. S., Etienne, M., Marchand, F. and Ardid, D. (2014). Monoarthritis-induced emotional and cognitive impairments in rats are sensitive to low systemic doses or intra-amygdala injections of morphine. Eur J Pharmacol 735: 1-9.
-
Thibault, K., Calvino, B., Rivals, I., Marchand, F., Dubacq, S., McMahon, S. B. and Pezet, S. (2014). Molecular mechanisms underlying the enhanced analgesic effect of oxycodone compared to morphine in chemotherapy-induced neuropathic pain. PLoS One 9(3): e91297.
-
Courteix, C., Ferrier, J., Marchand, F., Authier, N., Dupuis, A., Balayssac, D. and Eschalier, A. (2013). Animal Models of Toxic and Metabolic Neuropathic Pain. In: Handwerker, H. O. and Arendt-Nielsen, L. (eds). Pain Models: Translational Relevance and Applications, IASP Press, Washington, DC©.
-
Marchand, F., D'Mello, R., Yip, P. K., Calvo, M., Muller, E., Pezet, S., Dickenson, A. H. and McMahon, S. B. (2011). Specific involvement of atypical PKCzeta/PKMzeta in spinal persistent nociceptive processing following peripheral inflammation in rat. Mol Pain 7: 86.
-
D'Mello, R., Marchand, F., Pezet, S., McMahon, S. B. and Dickenson, A. H. (2011). Perturbing PSD-95 interactions with NR2B-subtype receptors attenuates spinal nociceptive plasticity and neuropathic pain. Mol Ther 19(10): 1780-1792.
-
Kaan, T. K., Yip, P. K., Patel, S., Davies, M., Marchand, F., Cockayne, D. A., Nunn, P. A., Dickenson, A. H., Ford, A. P., Zhong, Y., Malcangio, M. and McMahon, S. B. (2010). Systemic blockade of P2X3 and P2X2/3 receptors attenuates bone cancer pain behaviour in rats. Brain 133(9): 2549-2564.
-
Bishop, T., Marchand, F., Young, A. R., Lewin, G. R. and McMahon, S. B. (2010). Ultraviolet-B-induced mechanical hyperalgesia: A role for peripheral sensitisation. Pain 150(1): 141-152.
-
Clark, A. K., Staniland, A. A., Marchand, F., Kaan, T. K., McMahon, S. B. and Malcangio, M. (2010). P2X7-dependent release of interleukin-1beta and nociception in the spinal cord following lipopolysaccharide. J Neurosci 30(2): 573-582.
-
Marchand, F., Jones, N. G. and McMahon, S. B. (2009). Future treatment strategies for neuropathic pain. Handb Exp Pharmacol(194): 589-615.
-
Authier, N., Balayssac, D., Marchand, F., Ling, B., Zangarelli, A., Descoeur, J., Coudore, F., Bourinet, E. and Eschalier, A. (2009). Animal models of chemotherapy-evoked painful peripheral neuropathies. Neurotherapeutics 6(4): 620-629.
-
Pezet, S., Marchand, F., Thibault, K., Dauvergne, C., Grist, J., Smith, G. M., McMahon, S. B. and Calvino, B. (2009). Role of NGF in Neuronal Plasticity in the Lateral Reticular Nucleus in Chronic Inflammatory Pain. The Open Pain J.
-
Wodarski, R., Clark, A. K., Grist, J., Marchand, F. and Malcangio, M. (2009). Gabapentin reverses microglial activation in the spinal cord of streptozotocin-induced diabetic rats. Eur J Pain 13(8): 807-811.
-
Marchand, F., Tsantoulas, C., Singh, D., Grist, J., Clark, A. K., Bradbury, E. J. and McMahon, S. B. (2009). Effects of Etanercept and Minocycline in a rat model of spinal cord injury. Eur J Pain 13(7): 673-681.
-
Thacker, M. A., Clark, A. K., Bishop, T., Grist, J., Yip, P. K., Moon, L. D., Thompson, S. W., Marchand, F. and McMahon, S. B. (2009). CCL2 is a key mediator of microglia activation in neuropathic pain states. Eur J Pain 13(3): 263-272.
-
Bordet, T., Buisson, B., Michaud, M., Abitbol, J. L., Marchand, F., Grist, J., Andriambeloson, E., Malcangio, M. and Pruss, R. M. (2008). Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy. J Pharmacol Exp Ther 326(2): 623-632.
-
Pezet, S., Marchand, F., D'Mello, R., Grist, J., Clark, A. K., Malcangio, M., Dickenson, A. H., Williams, R. J. and McMahon, S. B. (2008). Phosphatidylinositol 3-kinase is a key mediator of central sensitization in painful inflammatory conditions. J Neurosci 28(16): 4261-4270.
-
Thacker, M. A., Clark, A. K., Marchand, F. and McMahon, S. B. (2007). Pathophysiology of peripheral neuropathic pain: immune cells and molecules. Anesth Analg 105(3): 838-847.
-
Clark, A. K., Yip, P. K., Grist, J., Gentry, C., Staniland, A. A., Marchand, F., Dehvari, M., Wotherspoon, G., Winter, J., Ullah, J., Bevan, S. and Malcangio, M. (2007). Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain. Proc Natl Acad Sci U S A 104(25): 10655-10660.
-
Barritt, A. W., Davies, M., Marchand, F., Hartley, R., Grist, J., Yip, P., McMahon, S. B. and Bradbury, E. J. (2006). Chondroitinase ABC promotes sprouting of intact and injured spinal systems after spinal cord injury. J Neurosci 26(42): 10856-10867.
-
Clark, A. K., D'Aquisto, F., Gentry, C., Marchand, F., McMahon, S. B. and Malcangio, M. (2006). Rapid co-release of interleukin 1beta and caspase 1 in spinal cord inflammation. J Neurochem 99(3): 868-880.
-
Marchand, F., Perretti, M. and McMahon, S. B. (2005). Role of the immune system in chronic pain. Nat Rev Neurosci 6(7): 521-532.
-
McMahon, S. B., Cafferty, W. B. and Marchand, F. (2005). Immune and glial cell factors as pain mediators and modulators. Exp Neurol 192(2): 444-462.